Health Care Law News and Insights

Why are prescription drug prices so high in the U.S.? While this question can hardly be considered a new topic in American healthcare, the recent clash of words between the Trump Administration and Democratic Senators has once again brought focus to the issue of prescription drug prices. According to the...

Read More

The US Court of Appeals for the Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) finding that tribal immunity does not apply to inter partes review (IPR) proceedings. Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals, Inc., et al., Case Nos. 18-1638, -1639, -1640, -1641, -1642, -1643 (Fed. Cir. July 20, 2018)...

Read More

Centers for Medicare & Medicaid Services (CMS) recently issued a Request for Information (RFI) seeking public comments on the regulatory burdens associated with the federal physician self-referral law, commonly known as the “Stark Law.” Although the RFI has a particular focus on the Stark Law as a potential barrier to...

Read More